Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synthesis and Characterization of a Novel, Ph-Responsive Sustained Release Nanocarrier Using Polyethylene Glycol, Graphene Oxide, and Natural Silk Fibroin Protein by a Green Nano Emulsification Method to Enhance Cancer Treatment Publisher Pubmed



Jeshvaghani PA1 ; Pourmadadi M1 ; Yazdian F2 ; Rashedi H3 ; Khoshmaram K2 ; Nigjeh MN4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
  2. 2. Department of Life Science Engineering, Faculty of New Science and Technologies, University of Tehran, Tehran, Iran
  3. 3. Department of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran
  4. 4. Pharmaceutical Sciences Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences (TUMS), Tehran, Iran
  5. 5. Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Source: International Journal of Biological Macromolecules Published:2023


Abstract

In this study, for the first time, by employing a simple and efficient double nano-emulsification method and using sweet almond oil as the organic phase, polyethylene glycol (PEG)/graphene oxide (GO)/silk fibroin (SF) hydrogel-nanocomposite was synthesized. The aim of the research was to fabricate a biocompatible targeted pH-sensitive sustained release carrier, improve the drug loading capacity and enhance the anticancer effect of doxorubicin (DOX) drug. The obtained values for the entrapment (%EE) and loading efficacy (%LE) were 87.75 ± 0.7 % and 46 ± 1 %, respectively, and these high values were due to the use of GO with a large specific surface area and the electrostatic interaction between the drug and SF. The Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analyses confirmed the presence of all the components in the nanocomposite and the suitable interaction between them. Based on the results of dynamic light scattering analysis (DLS) and zeta potential analysis, the mean size of the carrier particles and its surface charge were 293.7 nm and −102.9 mV, respectively. The high negative charge was caused by the presence of hydroxyl groups in GO and SF and it caused proper stability of the nanocomposite. The spherical core-shell structure with its homogeneous surface was also observed in the field emission scanning electron microscopy (FE-SEM) image. The cumulative release percentage of the nanocarrier reached 95.75 after 96 h and it is higher in the acidic environment at all times. The results of fitting the release data to the kinetic models suggested that the mechanism of release was dissolution-controlled anomalous at pH 7.4 and diffusion-controlled anomalous at pH 5.4. The results of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and flow cytometry showed an increase in toxicity on MCF-7 cells and improved apoptotic cell death compared to the free drug. Consequently, the findings of this research introduced and confirmed PEG/GO/SF nanocomposite as an attractive novel drug delivery system for pH-sensitive and sustained delivery of chemotherapeutic agents in biomedicine. © 2022 Elsevier B.V.
Experts (# of related papers)
Other Related Docs
14. Cisplatin-Loaded Nanoformulations for Cancer Therapy: A Comprehensive Review, Journal of Drug Delivery Science and Technology (2022)
27. Tio2-Based Nanocomposites for Cancer Diagnosis and Therapy: A Comprehensive Review, Journal of Drug Delivery Science and Technology (2023)
34. Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics, ACS Biomaterials Science and Engineering (2020)
44. Recent Trends in Controlled Drug Delivery Based on Silk Platforms, Silk-Based Biomaterials for Tissue Engineering# Regenerative# and Precision Medicine# 2nd Edition (2023)